CPH

Cipher Pharms

14.06

-0.21-1.47%

Closed16:00 09/24 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE14.23/14.27

TODAY RANGE13.96-14.23

VOL19.22K

MARKET CAP357.34M

52 WEEK RANGE12.48-20.56

AVG VOL (3M)34.33K

% TURNOVER0.08%

TURNOVER89.89K

P/E (TTM)8.82

% RANGE1.89%

EPS(TTM)1.595

P/E(FORWARD)12.51

P/B1.833

BVPS7.67

DIVIDEND--

P/S5.13

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP202.97M

SHARES OUTSTANDING25.42M

NEXT EARNINGS11/04-11/09

FREE FLOAT14.44M

LOT SIZE100

EX-DATE--

News

Press Releases

Financial Reports

Profile

Dow Jones·2d ago
Press Release: Cipher Pharmaceuticals Announces the Appointment of Rajiv De Silva to its Board of Directors
Dow Jones·08/11 21:04
*Cipher Pharmaceuticals 2Q EPS 15c >CPH.T
Dow Jones·08/11 21:04
*Cipher Pharmaceuticals 2Q Rev $12.1M >CPH.T
Dow Jones·08/11 21:00
Press Release: Cipher Pharmaceuticals Reports -2-
Dow Jones·06/18 17:00
Press Release: Cipher Pharmaceuticals Announces Results of Annual General Meeting of Shareholders
Dow Jones·05/12 15:36
Cipher Pharmaceuticals Price Target Is Maintained at C$17.00/Share by Canaccord Genuity
Dow Jones·05/12 15:36
Cipher Pharmaceuticals Is Maintained at Hold by Canaccord Genuity
Dow Jones·05/07 21:09
*Cipher Pharmaceuticals 1Q Rev $12.5M >CPH.T
Dow Jones·05/07 21:09
*Cipher Pharmaceuticals 1Q EPS 24c >CPH.T
Dow Jones·05/07 21:00
Press Release: Cipher Pharmaceuticals Reports -2-
Dow Jones·05/07 21:00
Press Release: Cipher Pharmaceuticals Reports -3-
Dow Jones·05/07 21:00
Press Release: Cipher Pharmaceuticals Reports First Quarter Results
Dow Jones·05/01 11:04
*Cipher Pharmaceuticals to Buy Back Up to 1.5M of Its Common Shrs Under NCIB >CPH.T
Dow Jones·05/01 11:04
*Cipher Pharmaceuticals Announces Normal Course Issuer Bid >CPH.T
Barron‘s·03/25 17:27
This Data Center Stock Is Surging on a Hyperscaler Deal. It's a Signal of AI Demand.

Same Industry

Name/Symbol

Change%

Price

No data yet, let's see others

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.

English